RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
GlaxoSmithKline - Stock

GlaxoSmithKline Dividend 2024

GlaxoSmithKline Dividend

0.56 GBP

GlaxoSmithKline Dividend yield

3.71 %

Ticker

GSK.L

ISIN

GB0009252882

WKN

940561

How much dividend does GlaxoSmithKline 2024 pay?

According to the latest status from July 2024, GlaxoSmithKline paid a total of 0.56 GBP per share in dividends within the last 12 months. With the current GlaxoSmithKline price of 15.04 GBP, this corresponds to a dividend yield of 3.71 %. A dividend is paid 4 times per year.

3.71 % Dividend Yield=
0.56 GBP Dividend
15.04 GBP Stock Price

Historical GlaxoSmithKline Dividends

A dividend is paid 4 times per year. Last year, the payout months were March, June, September and December.

PaydateDividend
6/16/20240.15
12/16/20230.14
9/17/20230.14
6/18/20230.14
3/23/20230.14
12/17/20220.14
9/18/20220.16
6/19/20220.14
3/24/20220.23
12/18/20210.19
9/19/20210.19
6/20/20210.19
3/18/20210.23
12/12/20200.19
9/13/20200.19
6/14/20200.19
3/20/20200.23
12/14/20190.19
9/8/20190.19
6/16/20190.19
1
2
3
4
5
...
6

GlaxoSmithKline Stock Dividend

In 2023, GlaxoSmithKline paid a dividend amounting to 0.56 GBP. Dividend means that GlaxoSmithKline distributes a portion of its profits to its owners.

  • 3 years

  • 5 years

  • 10 years

  • Max

Dividend
Dividend (Estimate)
Details

Dividend

ⓘ

Dividend Overview

The dividend per year chart for GlaxoSmithKline provides a comprehensive view of the annual dividends distributed to shareholders. Analyze the trend to understand the consistency and growth in dividend payouts over the years.

Interpretation and Use

A consistent or increasing trend in dividends can indicate the company's profitability and financial health. Investors can use this data to identify GlaxoSmithKline’s potential for long-term investment and income generation through dividends.

Investment Strategy

Incorporate the dividend data in evaluating GlaxoSmithKline's overall performance. A thorough analysis, considering other financial aspects, will help in making informed investment decisions for optimal capital growth and income generation.

GlaxoSmithKline Dividend History

DateGlaxoSmithKline Dividend
2029e1 undefined
2028e1.01 undefined
2027e1 undefined
2026e0.99 undefined
2025e1.04 undefined
2024e0.97 undefined
20230.56 undefined
20220.67 undefined
20210.8 undefined
20200.8 undefined
20190.8 undefined
20180.8 undefined
20170.8 undefined
20160.82 undefined
20151.11 undefined
20141.11 undefined
20130.97 undefined
20120.96 undefined
20110.94 undefined
20100.84 undefined
20090.83 undefined
20080.78 undefined
20070.71 undefined
20060.67 undefined
20050.58 undefined
20040.61 undefined

Is the GlaxoSmithKline Dividend Safe?

GlaxoSmithKline has been increasing the dividend for 3 years.

Over the past 10 years, GlaxoSmithKline has increased it by an annual -5.383 %.

Over a five-year period, the distribution increased by -6.968%.

Analysts expect a Dividend Increase of 32.04% for the current fiscal year.

GlaxoSmithKline Stock Payout Ratio

In 2023, GlaxoSmithKline had a payout ratio of 49.57%. The payout ratio indicates the percentage of the company's profits that GlaxoSmithKline distributes as dividends.

  • 3 years

  • 5 years

  • 10 years

  • Max

Payout ratio
Details

Payout ratio

ⓘ

What is Yearly Payout Ratio?

The yearly payout ratio for GlaxoSmithKline represents the proportion of earnings paid out as dividends to shareholders. It is an indicator of the company's financial health and stability, illustrating how much profit is being returned to investors versus being reinvested back into the company.

How to Interpret the Data

A lower payout ratio for GlaxoSmithKline could mean that the company is reinvesting more into its growth, whereas a higher ratio indicates more earnings are being distributed as dividends. Investors seeking regular income might prefer companies with a higher payout ratio, while those looking for growth may opt for companies with a lower ratio.

Using the Data for Investments

Evaluate GlaxoSmithKline's payout ratio in conjunction with other financial metrics and performance indicators. A sustainable payout ratio, coupled with strong financial health, can indicate a reliable dividend payout. However, a very high ratio might suggest the company is not sufficiently reinvesting in its future growth.

GlaxoSmithKline Payout Ratio History

DateGlaxoSmithKline Payout ratio
2029e43.69 %
2028e42.37 %
2027e43.6 %
2026e45.1 %
2025e38.4 %
2024e47.32 %
202349.57 %
202218.31 %
202174.07 %
202056.34 %
201969.11 %
201887.91 %
2017210.53 %
2016352.69 %
201564.49 %
2014194.93 %
201387.34 %
2012104.77 %
201191.69 %
2010262.13 %
200977.15 %
200888.39 %
200775.36 %
200670.18 %
200571.15 %
200481.48 %

Dividend Details

Understanding GlaxoSmithKline's Dividend Distributions

GlaxoSmithKline’s dividends are a portion of the company’s profits distributed to shareholders. It is a critical indicator of the company’s financial health and attractiveness to investors. Dividends provide investors with a steady income stream, in addition to any profits that may come from selling the stock at a higher price than the purchase price.

Year-to-Year Comparison

Examining GlaxoSmithKline's dividend distributions over the years can highlight the company’s profitability and stability. A consistent or increasing dividend payout can indicate a financially healthy company with predictable earnings, while fluctuations or reductions in dividends can suggest underlying financial or operational challenges.

Impact on Investments

GlaxoSmithKline's dividend payments are an essential factor for income-focused investors. A robust dividend payout can enhance the stock’s appeal, offering regular income in addition to potential capital gains. It also can indicate the company's confidence in its future earnings, making it a significant consideration in investment decisions.

Interpreting Dividend Fluctuations

Changes in GlaxoSmithKline’s dividends can result from shifts in the company’s earnings, financial policies, or reinvestment strategies. An increase in dividends often signals financial stability, while a decrease may indicate a need to conserve cash or reinvest profits to fuel growth, each scenario having different implications for investors.

GlaxoSmithKline Aktienanalyse

What does GlaxoSmithKline do?

GlaxoSmithKline PLC is a globally leading pharmaceutical company headquartered in London, UK. The company's history dates back to 1873 when the Burroughs Wellcome & Co firm was founded. In 2000, the company merged with Glaxo Wellcome to form the current GlaxoSmithKline PLC. GlaxoSmithKline's business model is to provide medical solutions for various diseases and health problems. The company heavily invests in research and development to develop new drugs and vaccines. It collaborates closely with government agencies, hospitals, doctors, and patient organizations to ensure better access to its products. The company is divided into three different divisions: Pharma, Vaccines, and Consumer Healthcare. The Pharma division is the largest and includes areas such as oncology, immunology, neuroscience, respiratory, and infectious diseases. GlaxoSmithKline is a leader in HIV treatment and is also active in the development of cancer drugs. The Vaccines division of GlaxoSmithKline is also very large and includes vaccines against various infectious diseases such as pneumococcus, influenza, and meningitis. It is also working on the development of vaccines against COVID-19. GlaxoSmithKline's Consumer Healthcare division includes products such as Sensodyne, Voltaren, Nicotinell, and Aquafresh. These products operate in the areas of oral health, pain relief, and smoking cessation. The focus is on a wide range of over-the-counter products available in pharmacies and supermarkets. An example of an important product of GlaxoSmithKline is the malaria vaccine developed in collaboration with the University of Oxford. The vaccine has the potential to save millions of lives in Africa. Currently, the vaccine is being tested in several African countries. GlaxoSmithKline PLC has also faced some controversies in the past, particularly related to the marketing of antidepressants. However, the company has taken measures to increase the transparency of its practices and operate ethically. Overall, GlaxoSmithKline is a significant pharmaceutical company that offers a wide range of medical products and solutions. It heavily invests in research and development to develop new products that can improve people's lives. The company also adopts an ethical approach in its business and advocates for better access to its products. GlaxoSmithKline is one of the most popular companies on Eulerpool.com.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The GlaxoSmithKline stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank

Frequently Asked Questions about GlaxoSmithKline stock

How much dividend does GlaxoSmithKline pay?

Over the past 12 months, GlaxoSmithKline paid a dividend of 0.56 GBP . This corresponds to a dividend yield of about 3.71 %. For the coming 12 months, GlaxoSmithKline is expected to pay a dividend of 1.04 GBP.

What is the dividend yield of GlaxoSmithKline?

The current dividend yield of GlaxoSmithKline is 3.71 %.

When does GlaxoSmithKline pay dividends?

GlaxoSmithKline pays a quarterly dividend. This is distributed in the months of June, September, December, June.

How secure is the dividend of GlaxoSmithKline?

GlaxoSmithKline paid dividends every year for the past 26 years.

What is the dividend of GlaxoSmithKline?

For the upcoming 12 months, dividends amounting to 1.04 GBP are expected. This corresponds to a dividend yield of 6.93 %.

In which sector is GlaxoSmithKline located?

GlaxoSmithKline is assigned to the 'Health' sector.

Wann musste ich die Aktien von GlaxoSmithKline kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of GlaxoSmithKline from 7/11/2024 amounting to 0.15 GBP, you needed to have the stock in your portfolio before the ex-date on 5/16/2024.

When did GlaxoSmithKline pay the last dividend?

The last dividend was paid out on 7/11/2024.

What was the dividend of GlaxoSmithKline in the year 2023?

In the year 2023, GlaxoSmithKline distributed 0.67 GBP as dividends.

In which currency does GlaxoSmithKline pay out the dividend?

The dividends of GlaxoSmithKline are distributed in GBP.

Andere Kennzahlen von GlaxoSmithKline

Our stock analysis for GlaxoSmithKline Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of GlaxoSmithKline Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.